Methofill

Methotrexate, the active ingredient in Methofill, is an Antimetabolite presented as a subcutaneous injection for Subcutaneous use. It is used to treat autoimmune disorders such as rheumatoid arthritis and psoriasis, as well as certain cancers, in adult patients.

GNH USA supplies Methofill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Methofill acts on rapidly dividing cells and immune pathways, making it useful across several disease families. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell proliferation and plaque formation. - Psoriatic arthritis: alleviates joint pain and skin symptoms. - Acute lymphoblastic leukemia: interferes with malignant cell replication. - Other malignancies: used as part of combination chemotherapy regimens.

Methofill may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea or vomiting: gastrointestinal upset is frequently reported. - Fatigue: patients often experience reduced energy levels. - Mouth sores: ulceration of oral mucosa may occur. - Elevated liver enzymes: mild hepatic irritation is common.

Serious or Rare Side Effects: - Bone marrow suppression: can lead to anemia, leukopenia, or thrombocytopenia. - Pulmonary toxicity: interstitial pneumonitis may develop. - Severe hepatic injury: rare cases of liver fibrosis or cirrhosis. - Renal impairment: reduced kidney function can occur. - Cutaneous reactions: severe skin rashes or Stevens‑Johnson syndrome.

Methofill requires careful monitoring and specific safety measures. - Pregnancy: contraindicated (Category X); avoid use in pregnant or trying-to-conceive patients. - Renal function: assess baseline kidney function and adjust if impairment is present. - Hepatic function: monitor liver enzymes regularly during therapy. - Blood counts: perform complete blood count before initiation and periodically thereafter. - Drug interactions: review concomitant medications for potential additive toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methofill can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of renal toxicity. - Proton pump inhibitors: may elevate methotrexate serum levels. - Trimethoprim‑sulfamethoxazole: potentiates bone marrow suppression.

Moderate Interactions (Monitor Closely): - Penicillins: may reduce renal clearance of methotrexate. - Sulfonamides: can enhance hematologic toxicity. - Live vaccines: immunosuppression may diminish vaccine efficacy.